Akso Health Group: Form 20-F for the period ended Mar 31, 2018
Filed with the SEC on Jul 30, 2018 and accepted by EDGAR at Jul 27, 2018, 18:21 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 12 months2017-04-01 to 2018-03-31 | $107.3m | us-gaap:GrossProfit |
| Research and development | 12 months2017-04-01 to 2018-03-31 | $2.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2017-04-01 to 2018-03-31 | $75.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2017-04-01 to 2018-03-31 | $11.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2017-04-01 to 2018-03-31 | $65.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2017-04-01 to 2018-03-31 | $1.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2017-04-01 to 2018-03-31 | $1.46 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-04-01 to 2018-03-31 | 47,656,263 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2017-04-01 to 2018-03-31 | $87.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2017-04-01 to 2018-03-31 | $456.0k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2018-03-31 | $132.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2018-03-31 | $163.9m | us-gaap:Assets |
| Total liabilities | At period end2018-03-31 | $23.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-03-31 | $140.0m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-03-31 | 47,958,550 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-18-047800. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.